AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9887116 — intervention group
Group type: COMPARATOR
Intervention: Unflavored water (W)
Number of subjects: 12
Study 8770842 — intervention group
Group type: EXPERIMENTAL
Intervention: Thrombolytic therapy
Number of subjects: 0
Study 8770842 — intervention group
Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study 2039639 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous alfentanil infusion (100 micrograms/kg bolus followed by continuous infusion)
Number of subjects: 40
Study 2039639 — intervention group
Group type: COMPARATOR
Intervention: Halothane and nitrous oxide (N2O)
Number of subjects: 40
Study 7469185 — intervention group
Group type: EXPERIMENTAL
Intervention: Drained group
Number of subjects: 76
Study 7469185 — intervention group
Group type: COMPARATOR
Intervention: Nondrained group
Number of subjects: 76
Study 6696838 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA-etretinate (1 mg/kg)
Number of subjects: 20
Study 6696838 — intervention group
Group type: COMPARATOR
Intervention: PUVA-placebo
Number of subjects: 20
Study 6696838 — intervention group
Group type: EXPERIMENTAL
Intervention: PUVA-etretinate
Number of subjects: 20
Study 29382509 — intervention group
Group type: EXPERIMENTAL
Intervention: Active Tube Clearance (ATC)
Number of subjects: 581
Study 29382509 — intervention group
Group type: COMPARATOR
Intervention: Control (conventional chest tubes)
Number of subjects: 581
Study 27965296 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred Stenting (DS)
Number of subjects: 114
Study 27965296 — intervention group
Group type: COMPARATOR
Intervention: Immediate Stenting (IS)
Number of subjects: 114
Study 27965296 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred Stenting (DS) in anterior wall myocardial infarction
Number of subjects: 114
Study 27965296 — intervention group
Group type: COMPARATOR
Intervention: Immediate Stenting (IS) in anterior wall myocardial infarction
Number of subjects: 114
Study 24535759 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryolipolysis treatment on the flank
Number of subjects: 11
Study 24535759 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated flank)
Number of subjects: 11
Study 23769296 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg ustekinumab
Number of subjects: 615
Study 23769296 — intervention group
Group type: EXPERIMENTAL
Intervention: 90 mg ustekinumab
Number of subjects: 615
Study 23769296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 615
Study 23769296 — intervention group
Group type: EXPERIMENTAL
Intervention: Ustekinumab (both doses)
Number of subjects: 615
Study 20508011 — intervention group
Group type: EXPERIMENTAL
Intervention: Static progressive stretch brace
Number of subjects: 13
Study 20508011 — intervention group
Group type: COMPARATOR
Intervention: Active stretching exercises
Number of subjects: 13
Study 18972276 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (320/9 microg 4 times daily)
Number of subjects: 45
Study 18972276 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 16649833 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence with antipsychotic medication
Number of subjects: 1906
Study 16649833 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonadherence in the first year
Number of subjects: 1906
Study 16649833 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence status
Number of subjects: 1906
Study 14563970 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluoromisonidazole PET imaging within 6 hours of stroke onset
Number of subjects: 19
Study 14563970 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluoromisonidazole PET imaging after 6 hours of stroke onset
Number of subjects: 19
Study 14563970 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F‐fluoromisonidazole PET imaging
Number of subjects: 19
Study 14563970 — intervention group
Group type: COMPARATOR
Intervention: 15 age‐matched controls
Number of subjects: 19
Study 10971268 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 160/120 (saw palmetto fruit and nettle root extract)
Number of subjects: 431
Study 10971268 — intervention group
Group type: COMPARATOR
Intervention: Finasteride
Number of subjects: 431
Study 10971268 — intervention group
Group type: EXPERIMENTAL
Intervention: PRO 160/120
Number of subjects: 431
Study 10971268 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 431
Study 8880834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia patients
Number of subjects: 20
Study 8880834 — intervention group
Group type: EXPERIMENTAL
Intervention: Rheumatoid arthritis patients
Number of subjects: 20
Study 8880834 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 20
Study 8880834 — intervention group
Group type: EXPERIMENTAL
Intervention: Fibromyalgia and RA patients
Number of subjects: 20
Study 1403581 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue applied subgingivally for 7 days
Number of subjects: 7
Study 1403581 — intervention group
Group type: COMPARATOR
Intervention: Sterile water (control)
Number of subjects: 7
Study 3986895 — intervention group
Group type: EXPERIMENTAL
Intervention: Pizotifen (0.5 mg t.i.d.)
Number of subjects: 35
Study 3986895 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol (50 mg b.i.d.)
Number of subjects: 35
Study 31876175 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification intervention
Number of subjects: 196
Study 31876175 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification with primary care physician sharing
Number of subjects: 196
Study 31876175 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 196
Study 29497289 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium delivered via HandiHaler® (18 μg once daily) or Respimat® Soft Mist™ (2.5 or 5 μg once daily)
Number of subjects: 17116
Study 27116024 — intervention group
Group type: EXPERIMENTAL
Intervention: Three oral formulations of ciprofloxacin
Number of subjects: 16
Study 27116024 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of ciprofloxacin
Number of subjects: 16
Study 27116024 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro ciprofloxacin release testing
Number of subjects: 16
Study 27116024 — intervention group
Group type: EXPERIMENTAL
Intervention: Mechanistic absorption models
Number of subjects: 16
Study 24330381 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.1%
Number of subjects: 30
Study 24330381 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.2%
Number of subjects: 30
Study 22142495 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle exercise programme
Number of subjects: 66
Study 22142495 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study 20400095 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose eplerenone (25 mg daily)
Number of subjects: 304
Study 20400095 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle-dose eplerenone (25 mg twice daily)
Number of subjects: 304
Study 20400095 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose eplerenone (50 mg twice daily)
Number of subjects: 304
Study 20400095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 304
Study 18208957 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehomecare units with peripheral devices (blood-pressure monitor, weight scale, glucometer, pulse oximeter) installed in patients' homes, monitored by nurse practitioners.
Number of subjects: 22
Study 18208957 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehomecare monitoring system
Number of subjects: 22
Study 16200612 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid (1 mg orally once or twice daily)
Number of subjects: 668
Study 16200612 — intervention group
Group type: COMPARATOR
Intervention: Non-folic acid
Number of subjects: 668
Study 16200612 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid
Number of subjects: 668
Study 14723396 — intervention group
Group type: EXPERIMENTAL
Intervention: Skinfold calipers
Number of subjects: 332
Study 14723396 — intervention group
Group type: EXPERIMENTAL
Intervention: Inexpensive plastic Fat Control calipers
Number of subjects: 332
Study 14723396 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 332
Study 10988305 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 46
Study 10988305 — intervention group
Group type: COMPARATOR
Intervention: Preoperative autologous blood donation (PABD)
Number of subjects: 46
Study 8902371 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheterization (PAC)
Number of subjects: 0
Study 8902371 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based medicine
Number of subjects: 0
Study 8902371 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology assessment
Number of subjects: 0
Study 1452369 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum cortisol levels
Number of subjects: 70
Study 6483504 — intervention group
Group type: EXPERIMENTAL
Intervention: DL-carnitine, 100 mg/kg/day for 4 days
Number of subjects: 132
Study 30482254 — intervention group
Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA)
Number of subjects: 0
Study 30482254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28549895 — intervention group
Group type: EXPERIMENTAL
Intervention: Needle-free jet lidocaine (J-tip) administration (0.25 mL of 2% lidocaine)
Number of subjects: 100
Study 28549895 — intervention group
Group type: COMPARATOR
Intervention: Simultaneous lidocaine injection (0.5 mL of 1% lidocaine) with corticosteroid
Number of subjects: 100
Study 25682258 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to the film 'Into the wild'
Number of subjects: 154
Study 25682258 — intervention group
Group type: COMPARATOR
Intervention: Control group (no film exposure)
Number of subjects: 154
Study 24104763 — intervention group
Group type: EXPERIMENTAL
Intervention: Target-controlled infusion (TCI) of propofol 10 mg/mL, initial targeted effect-site concentration 2 μg/mL
Number of subjects: 82
Study 24104763 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled sedation (PCS) of propofol, single bolus 1 mL, lockout time set at zero
Number of subjects: 82
Study 24104763 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of propofol and alfentanil
Number of subjects: 82
Study 20966170 — intervention group
Group type: EXPERIMENTAL
Intervention: G-PBSCs plus induction chemotherapy with cytarabine and mitoxantrone
Number of subjects: 58
Study 20966170 — intervention group
Group type: COMPARATOR
Intervention: Induction chemotherapy with cytarabine and mitoxantrone (control group)
Number of subjects: 58
Study 18324934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (physicians received the Pressure System Model training)
Number of subjects: 381
Study 18324934 — intervention group
Group type: COMPARATOR
Intervention: Control group (physicians received usual residency training)
Number of subjects: 381
Study 18324934 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (residents provided PA counselling)
Number of subjects: 381
Study 18324934 — intervention group
Group type: COMPARATOR
Intervention: Control group (residents provided PA counselling)
Number of subjects: 381
Study 16420978 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety-mediated gait adaptations
Number of subjects: 28
Study 16420978 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxiety-mediated gait adaptations among older adults
Number of subjects: 28
Study 12740515 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep endotracheal suctioning (ETS)
Number of subjects: 22
Study 12740515 — intervention group
Group type: COMPARATOR
Intervention: Shallow endotracheal suctioning (ETS)
Number of subjects: 22
Study 11004288 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 20
Study 11004288 — intervention group
Group type: COMPARATOR
Intervention: Timolol-XE
Number of subjects: 20
Study 8793415 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (0, 0.2, 0.4, 0.9, 1.3 g DHA/day)
Number of subjects: 0
Study 8793415 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of hepatitis A vaccine (group 1)
Number of subjects: 114
Study 1335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses given simultaneously (group 2)
Number of subjects: 114
Study 1335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses at days 0 and 14 (group 3)
Number of subjects: 114
Study 1335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses at days 0 and 28 (group 4)
Number of subjects: 114
Study 1335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses at days 0, 7 and 21 (group 5)
Number of subjects: 114
Study 1335642 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 1)
Number of subjects: 114
Study 1335642 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing for anti‐HAV immunoglobulin M (IgM)
Number of subjects: 114
Study 6746968 — intervention group
Group type: EXPERIMENTAL
Intervention: Whitaker Index of Schizophrenic Thinking (WIST)
Number of subjects: 85
Study 6746968 — intervention group
Group type: COMPARATOR
Intervention: 13 different interview systems for diagnosing schizophrenic disorders
Number of subjects: 85
Study 31266520 — intervention group
Group type: EXPERIMENTAL
Intervention: Triclosan-coated poliglecaprone 25 sutures
Number of subjects: 364
Study 31266520 — intervention group
Group type: COMPARATOR
Intervention: Un-coated suture material
Number of subjects: 364
Study 29720208 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based ecological momentary assessment and intervention (EMA/I) in conjunction with a four-session intervention
Number of subjects: 34
Study 29720208 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 34
Study 26020827 — intervention group
Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5% gel
Number of subjects: 233
Study 26020827 — intervention group
Group type: COMPARATOR
Intervention: Prednisolone acetate 1% solution
Number of subjects: 233
Study 24320999 — intervention group
Group type: EXPERIMENTAL
Intervention: Zumba training (twice a week for 8 weeks)
Number of subjects: 30
Study 24320999 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 30
Study 21669534 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 ml 0.5% plain bupivacaine
Number of subjects: 44
Study 21669534 — intervention group
Group type: COMPARATOR
Intervention: 20 ml normal saline (Control)
Number of subjects: 44
Study 19683149 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof single-piece intraocular lens (IOL) implantation in myopia group
Number of subjects: 100
Study 19683149 — intervention group
Group type: COMPARATOR
Intervention: AcrySof single-piece intraocular lens (IOL) implantation in control group
Number of subjects: 100
Study 17296394 — intervention group
Group type: EXPERIMENTAL
Intervention: Sonourethrography
Number of subjects: 93
Study 17296394 — intervention group
Group type: COMPARATOR
Intervention: Radio urethrography
Number of subjects: 93
Study 15464704 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care (usual care plus a coordinator for follow-up appointments and reminders)
Number of subjects: 125
Study 15464704 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced care
Number of subjects: 125
Study 15464704 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 125
Study 11345497 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT with luminance of 90 cd m(‐2) without city noise
Number of subjects: 4
Study 11345497 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT with luminance of 20 cd m(‐2) without city noise
Number of subjects: 4
Study 11345497 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT with luminance of 90 cd m(‐2) with city noise of 70 dB(A)
Number of subjects: 4
Study 11345497 — intervention group
Group type: EXPERIMENTAL
Intervention: VDT with luminance of 20 cd m(‐2) with city noise of 70 dB(A)
Number of subjects: 4
Study 9531132 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine/morphine (1 mg morphine with 40 mL of 0.25% bupivacaine)
Number of subjects: 50
Study 9531132 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (40 mL of 0.25% bupivacaine)
Number of subjects: 50
Study 8796759 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective vacuum extraction
Number of subjects: 1428
Study 8796759 — intervention group
Group type: COMPARATOR
Intervention: Normal spontaneous vaginal delivery
Number of subjects: 1428
Study 8796759 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum extraction in suspected fetal distress
Number of subjects: 1428
Study 2158614 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin-vinblastine
Number of subjects: 151
Study 2158614 — intervention group
Group type: EXPERIMENTAL
Intervention: cisplatin-ara-C
Number of subjects: 151
Study 7193030 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide in patients with impaired liver function
Number of subjects: 0
Study 7193030 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide in an anuric patient
Number of subjects: 0
Study 7193030 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 0
Study 31529622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 100 mg
Number of subjects: 5236
Study 31529622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan 200 mg
Number of subjects: 5236
Study 31529622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5236
Study 31529622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan (50, 100, or 200 mg)
Number of subjects: 5236
Study 31529622 — intervention group
Group type: EXPERIMENTAL
Intervention: Lasmiditan (100 or 200 mg)
Number of subjects: 5236
Study 26976091 — intervention group
Group type: EXPERIMENTAL
Intervention: Escitalopram, 10 mg/7 days
Number of subjects: 154
Study 26976091 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study 23231574 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Weight 2 group-based 4-hr prevention program
Number of subjects: 398
Study 23231574 — intervention group
Group type: COMPARATOR
Intervention: Educational brochure control condition
Number of subjects: 398
Study 21765256 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 24
Study 21765256 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 24
Study 19352302 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin
Number of subjects: 47
Study 19352302 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 47
Study 16918728 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric saline-intravenous motilin infusion
Number of subjects: 10
Study 16918728 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric acid-intravenous motilin infusion
Number of subjects: 10
Study 16918728 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric saline-intravenous motilin infusion and intragastric acid-intravenous saline infusion
Number of subjects: 10
Study 16918728 — intervention group
Group type: COMPARATOR
Intervention: Control (intragastric saline-intravenous saline)
Number of subjects: 10
Study 15579527 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering of prednisolone (TAP) from 16 mg (range 10 to 30) to 9 mg (range 5 to 12.5) daily
Number of subjects: 57
Study 15579527 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tapering of prednisolone)
Number of subjects: 57
Study 15579527 — intervention group
Group type: EXPERIMENTAL
Intervention: Steroid withdrawal (SW) of 5 mg prednisolone
Number of subjects: 57
Study 11800172 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene
Number of subjects: 0
Study 10322888 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined TCM-WM therapy (TCM-Tangxinshen, TXS) for three months, alongside WM for blood sugar control.
Number of subjects: 60
Study 10322888 — intervention group
Group type: COMPARATOR
Intervention: WM alone for three months.
Number of subjects: 60
Study 8465163 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative physiotherapy
Number of subjects: 39
Study 8465163 — intervention group
Group type: COMPARATOR
Intervention: Control group (no preoperative therapy)
Number of subjects: 39
Study 8465163 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (after surgery)
Number of subjects: 39
Study 3517560 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg BAY m1099
Number of subjects: 9
Study 3517560 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg BAY o1248
Number of subjects: 9
Study 3517560 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 31117920 — intervention group
Group type: EXPERIMENTAL
Intervention: SPG stimulation
Number of subjects: 253
Study 31117920 — intervention group
Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 253
Study 31117920 — intervention group
Group type: EXPERIMENTAL
Intervention: SPG stimulation (in patients with confirmed cortical involvement)
Number of subjects: 253
Study 31117920 — intervention group
Group type: COMPARATOR
Intervention: Sham control (in patients with confirmed cortical involvement)
Number of subjects: 253
Study 29908954 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG)
Number of subjects: 0
Study 29908954 — intervention group
Group type: EXPERIMENTAL
Intervention: Care as Usual Group (CAUG)
Number of subjects: 0
Study 29908954 — intervention group
Group type: COMPARATOR
Intervention: Never-Institutionalized Group (NIG)
Number of subjects: 0
Study 27670388 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) performed three times at intervals of 3 days
Number of subjects: 61
Study 27670388 — intervention group
Group type: COMPARATOR
Intervention: Local subacromial injection (corticosteroid and local anesthetic)
Number of subjects: 61
Study 25448627 — intervention group
Group type: EXPERIMENTAL
Intervention: DVD-delivered exercise intervention for 6 months
Number of subjects: 0
Study 25448627 — intervention group
Group type: COMPARATOR
Intervention: Attentional control condition
Number of subjects: 0
Study 22949279 — intervention group
Group type: EXPERIMENTAL
Intervention: Web-based intervention with e-mail discussion
Number of subjects: 73